Ticker
LPCNCompany Name
LIPOCINE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 6.04M | 4.17 | $ 1.45M |
3/31/2025 | $ 3.35M | 2.58 | $ 1.3M |
12/31/2024 | $ 6.21M | 4.1 | $ 1.51M |
9/30/2024 | $ 3.74M | 2.37 | $ 1.58M |
6/30/2024 | $ 5.55M | 3.04 | $ 1.82M |
3/31/2024 | $ 3.08M | 2.07 | $ 1.49M |
12/31/2023 | $ 4.77M | 1.81 | $ 2.63M |
9/30/2023 | $ 4.07M | 1.82 | $ 2.24M |
6/30/2023 | $ 5.01M | 2.74 | $ 1.83M |
3/31/2023 | $ 4.77M | 2.47 | $ 1.93M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for LIPOCINE INC is calculated as follows: CashnEq [ $ 17.94M ] / LiabilitesC [ $ 5.79M ]
(=) Cash Ratio [ 3.1 ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |